Harbor Advisors’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Harbor Advisors’s Portfolio RNLX Stock Details RNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-24,084	Closed	-$45K	–	162
2022 Q4	$45K	Hold	24,084	–	–	0.01%	156
2022 Q3	$31K	Hold	24,084	–	–	0.01%	161
2022 Q2	$59K	Hold	24,084	–	–	0.01%	167
2022 Q1	$167K	Buy	24,084 +5,500	+30%	+$58.3K	0.03%	156
2021 Q4	$295K	Buy	18,584 +8,584	+86%	+$172K	0.05%	129
2021 Q3	$201K	Hold	10,000	–	–	0.04%	156
2021 Q2	$309K	Hold	10,000	–	–	0.06%	129
2021 Q1	$257K	Hold	10,000	–	–	0.06%	143
2020 Q4	$160K	Hold	10,000	–	–	0.04%	155
2020 Q3	$122K	Buy	+10,000	New	+$144K	0.03%	147

Other funds holding RNLX

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NSIM

North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Harbor Advisors's RNLX Position: Q1 2023 in Review

Harbor Advisors sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2023, closing a stake of 24,084 shares — an estimated $45K sold.

Harbor Advisors first reported a position in RNLX in Q3 2020 and held it in 10 quarters. The position peaked at $309K in Q2 2021. 18 funds tracked by Wall St. Rank hold RNLX as of Q1 2023.

Harbor Advisors reported no remaining Renalytix plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Harbor Advisors sold 24,084 Renalytix plc American Depositary Shares shares in Q1 2023, an estimated $45K.
Harbor Advisors first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and held it in 10 quarters.
Harbor Advisors's Renalytix plc American Depositary Shares position peaked at $309K in Q2 2021.
18 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2023.

Based on Harbor Advisors's 13F filing for Q1 2023, filed 11 May 2023.